GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS
The global GM1 gangliosidosis treatment market size is estimated to be valued at US$ 142.1 million in 2025 and is expected to exhibit a CAGR of 35.6 % during the forecast period (2025-2030).
Figure 1. Global GM1 Gangliosidosis Treatment Market Value (US$ Mn), 2025 - 2030
Market- Trends:
GM1 gangliosidosis is a rare central nervous system disorder and can develop throughout the lifetime in diagnosed individuals. For instance, in 2019, according to World Health Organization WHO data, around 2,000 patients suffer from GM1 ganglioside across the world. According to the same data source, incidence GM1 gangliosidosis accounts for around 0.5-1.0/100,000 births across the globe.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
